𝔖 Bobbio Scriptorium

✦ LIBER ✦

Reply to Tomasz Drewa's Letter to the Editor re: Per-Anders Abrahamsson. Potential benefits of intermittent androgen suppression therapy in the treatment of prostate cancer: a systematic review of the literature. Eur Urol 2010;57:49–59

✍ Scribed by Per-Anders Abrahamsson; Jens A. Ceder

Book ID: 113611852
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 62 KB
Volume: 58
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2010.03.042

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Re: Per-Anders Abrahamsson. Potential Be

Re: Per-Anders Abrahamsson. Potential Benefits of Intermittent Androgen Suppression Therapy in the Treatment of Prostate Cancer: A Systematic Review of the Literature. Eur Urol 2010;57:49–59

✍ Tomasz Drewa 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Potential Benefits of Intermittent Andro

Potential Benefits of Intermittent Androgen Suppression Therapy in the Treatment of Prostate Cancer: A Systematic Review of the Literature

✍ Per-Anders Abrahamsson 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 367 KB

Reply to Tomasz Drewa's Letter to the Ed

Reply to Tomasz Drewa's Letter to the Editor re: Fritz H. Schröder. Progress in Understanding Androgen-Independent Prostate Cancer (AIPC): A Review of Potential Endocrine-Mediated Mechanisms. Eur Urol. 2008;53:1129–37

✍ Fritz H. Schröder 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Reply to Bernard Tombal's Letter to the

Reply to Bernard Tombal's Letter to the Editor re: Alessandro Sciarra, Per Anders Abrahamsson, Maurizio Brausi, et al. Intermittent Androgen-deprivation Therapy in Prostate Cancer: A Critical Review Focused on Phase 3 Trials. Eur Urol 2013;64:722–30

✍ Sciarra, Alessandro 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Reply to Magdi Mounir Kirollos’ Letter t

Reply to Magdi Mounir Kirollos’ Letter to the Editor re: Urs E. Studer, Laurence Collette, Peter Whelan, et al. Using PSA to Guide Timing of Androgen Deprivation in Patients with T0–4 N0–2 M0 Prostate Cancer Not Suitable for Local Curative Treatment (EORTC 30891). Eur Urol 2008;53:941–9 and re: John Anderson. Androgen Deprivation Therapy—It's All a Matter of Timing. Eur Urol 2008;53:869–71

✍ Urs E. Studer; Laurence Collette 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Reply to C. Mary Schooling, Grace Sembaj

Reply to C. Mary Schooling, Grace Sembajwe and Ilir Agalliu's Letter to the Editor re: Christina G. Jespersen, Mette Nørgaard, Michael Borre. Androgen-deprivation Therapy in Treatment of Prostate Cancer and Risk of Myocardial Infarction and Stroke: A Nationwide Danish Population-based Cohort Study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.02.002

✍ Jespersen, Christina Gade; Nørgaard, Mette; Borre, Michael 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 83 KB